Movement Disorders ProgramThe Movement Disorders Program evaluates, diagnoses, and treats all movement disorders including:
- Parkinson’s disease
- Restless leg syndrome
- Huntington’s disease or chorea
Dr. Way is the principal investigator of the PROSEEK study at Renown. PROSEEK is a drug trial that is studying a c-Abl inhibitor developed by SUN pharmaceuticals that has shown promise in slowing the progression of Parkinson’s disease. To be a candidate for the study, one must fulfill at least the following criteria:
- Age > 50 years
- Diagnosed with Parkinson’s disease within the last 3 years
- Not on medication for treatment of Parkinson’s disease aside from monoamine oxidase B (MAOB) inhibitors.
The PROSEEK Study is a clinical research study evaluating a once-daily, oral investigational drug for people with early-stage Parkinson’s disease (PD). The investigational drug is designed to block a specific enzyme called “Abl.” Research has shown that overactivation of Abl may play a role in PD progression. Therefore, by limiting or blocking Abl, it may be possible to help to slow PD progression.
Programs & Services
- Acute Rehab Hospital
- Epilepsy Program
- Headache Program
- Interventional Neuroradiology
- Memory Disorders Program
- Movement Disorders Program
- Multiple Sclerosis Program
- Outpatient Therapy
- Neuro ICU
- Neurosciences Clinical Trials
- Neurovascular & Stroke Program
- Spine, Sports & Pain Management
Grab your skis, goggles, coat – and don’t forget that helmet. Skiing and snowboarding are fun activities for all ages but come with the risk of injury. Read on for tips to make it a safe day on the mountain.
November is National Alzheimer’s Disease Awareness Month. At Renown Health, we know that Alzheimer's safety for your loved one is a priority, as the symptoms can sometimes lead to unsafe situations. We asked Dr. Jonathan Artz –
It’s important to be aware of the risk of a concussion, which can have serious health implications. Susan Park, MD, discusses the effects of concussions and how they can be prevented.
According to Susan Park, MD, a Renown Medical Group